Biren Amin
About Biren Amin
Biren Amin serves as the Managing Director at Piper Sandler, having previously held significant roles in finance and research within the biotechnology and pharmaceutical sectors. His extensive experience includes positions at Immuneering Corporation, Aventis Pharmaceuticals, and Stanford Group, among others.
Current Role at Piper Sandler
Biren Amin serves as Managing Director at Piper Sandler, a position he has held since 2024. His role involves leading initiatives within the firm and contributing to the healthcare equity research team. The position is based in New Jersey and operates in a hybrid work environment.
Previous Experience at Immuneering Corporation
Prior to his current role, Biren Amin was the Chief Financial Officer at Immuneering Corporation from 2021 to 2022. His tenure lasted one year and was conducted in a hybrid setting in New York. In this role, he was responsible for overseeing financial strategies and operations.
Background in Pharmaceuticals and Biotechnology
Biren Amin has extensive experience in the pharmaceutical and biotechnology sectors. He worked at Aventis Pharmaceuticals as Senior Manager of Scientific Competitive Intelligence from 1999 to 2004. He also held positions at Prudential Financial and Stanford Group, focusing on large-cap pharmaceuticals and biotechnology equity research.
Education and Expertise
Biren Amin holds an M.B.A. from NYU Stern School of Business. He also earned an M.S. in Pharmacy from Long Island University and a B.S. in Pharmacy from the University of the Sciences in Philadelphia. His educational background supports his expertise in finance and pharmaceuticals.
Board Memberships and Community Involvement
Biren Amin is actively involved in community service as a Member of the Board of Trustees for The Axiom REACH Foundation since 2022. He also served as a Board Member and Head of the Audit Committee at ImmPACT Bio from 2023 to 2024, contributing to governance and oversight.